Lignans from Dysosma versipellis with Inhibitory Effects on Prostate Cancer Cell Lines

A new monoepoxylignan, dysosmarol (1), along with eight known compounds, podophyllotoxin (2), 4‘-demethylpodophyllotoxin (3), deoxypodophyllotoxin (4), 4‘-demethyldeoxypodophyllotoxin (5), diphyllin (6), kaempferol, quercetin, and β-sitosterol, were isolated from the roots of Dysosma versipellis. Th...

Full description

Saved in:
Bibliographic Details
Published inJournal of natural products (Washington, D.C.) Vol. 70; no. 2; pp. 283 - 286
Main Authors Jiang, Ren-Wang, Zhou, Jin-Rong, Hon, Po-Ming, Li, Song-Lin, Zhou, Yan, Li, Ling-Lin, Ye, Wen-Cai, Xu, Hong-Xi, Shaw, Pang-Chui, But, Paul Pui-Hay
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 01.02.2007
Amer Chemical Soc
American Society of Pharmacognosy
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A new monoepoxylignan, dysosmarol (1), along with eight known compounds, podophyllotoxin (2), 4‘-demethylpodophyllotoxin (3), deoxypodophyllotoxin (4), 4‘-demethyldeoxypodophyllotoxin (5), diphyllin (6), kaempferol, quercetin, and β-sitosterol, were isolated from the roots of Dysosma versipellis. The structure of 1 was elucidated by spectroscopic methods. Aryltetralin lignans 2−4 showed the most potent inhibitory activities against the growth of androgen-sensitive (LNCaP) and androgen-independent (PC-3) human prostate cancer cell lines, with IC50 values in the ranges 0.030−0.056 and 0.032−0.082 μM, respectively. A quantitative HPLC analysis showed that compound 2 occurred at the highest concentration in the plant (37.21 mg/g) followed by compound 4 (5.01 mg/g) and compound 3 (2.75 mg/g). Furthermore, D. versipellis roots contain a similar content of compound 2 as compared with the rhizomes and roots of Podophyllum hexandrum, a commercial source of the lignan. Thus, cultivation of D. versipellis in suitable locations may serve as an alternative source for podophyllotoxin (2) production.
Bibliography:http://dx.doi.org/10.1021/np060430o
ark:/67375/TPS-F7K03J90-R
istex:F3B2775DD3604861D29FD080AD9BAF78D976F246
Dedicated to Professor Thomas C. W. Mak of the Chinese University of Hong Kong on the occasion of his 70th birthday.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Harvard Medical School.
Jinan University.
Hong Kong Jockey Club Institute of Chinese Medicine.
The Chinese University of Hong Kong.
ISSN:0163-3864
1520-6025
DOI:10.1021/np060430o